Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Baxter
Argus Health
Daiichi Sankyo
Citi
Cipla
Johnson and Johnson
McKesson
Boehringer Ingelheim

Generated: August 17, 2018

DrugPatentWatch Database Preview

BUTALBITAL, ACETAMINOPHEN AND CAFFEINE Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Butalbital, Acetaminophen And Caffeine, and what generic alternatives are available?

Butalbital, Acetaminophen And Caffeine is a drug marketed by Gilbert Labs, Graham Dm, Hikma Pharms, Mallinckrodt, Mayne Pharma Inc, Nexgen Pharma, Nuvo Pharm Inc, Tedor Pharma Inc, Mikart, Able, Actavis Labs Ut Inc, Cnty Line Pharms, Lannett Co Inc, Mirror Pharms Llc, Novast Labs Ltd, Specgx Llc, Sun Pharm Industries, Vintage Pharms, and Watson Labs. and is included in twenty-nine NDAs.

The generic ingredient in BUTALBITAL, ACETAMINOPHEN AND CAFFEINE is acetaminophen; butalbital; caffeine. There are sixty-six drug master file entries for this compound. Forty-five suppliers are listed for this compound. Additional details are available on the acetaminophen; butalbital; caffeine profile page.

Summary for BUTALBITAL, ACETAMINOPHEN AND CAFFEINE
Drug patent expirations by year for BUTALBITAL, ACETAMINOPHEN AND CAFFEINE
Pharmacology for BUTALBITAL, ACETAMINOPHEN AND CAFFEINE
Synonyms for BUTALBITAL, ACETAMINOPHEN AND CAFFEINE
122018-95-5
AC1MIWIF
Acetamide, N-(4-hydroxyphenyl)-, mixt. with 3,7-dihydro-1,3,7-trimethyl-1H-purine-2,6-dione and 5-(2-methylpropyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione
Acetaminophen mixture with butalbital and caffeine
Acetaminophen mixture with caffeine and butalbital
ACETAMINOPHEN, BUTALBITAL AND CAFFEINE
ACETAMINOPHEN, BUTALBITAL, AND CAFFEINE
Alagesic
Amaphen
Americet
Anolor
Arcet
Butace
BUTALBITAL, APAP, AND CAFFEINE
Capacet
DTXSID50153479
Endolor
Esgic Plus
Ezol
HE302168
LS-187804
Medigesic
N-(4-hydroxyphenyl)acetamide; 5-(2-methylpropyl)-5-prop-2-enyl-1,3-diazinane-2,4,6-trione; 1,3,7-trimethylpurine-2,6-dione
Orbivan
Pacaps
Repan
SCHEMBL2523453
Tencet
Zebutal

US Patents and Regulatory Information for BUTALBITAL, ACETAMINOPHEN AND CAFFEINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs BUTALBITAL, ACETAMINOPHEN AND CAFFEINE acetaminophen; butalbital; caffeine TABLET;ORAL 089536-001 Feb 16, 1988 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Watson Labs BUTALBITAL, ACETAMINOPHEN AND CAFFEINE acetaminophen; butalbital; caffeine TABLET;ORAL 040267-001 Jul 30, 1998 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Gilbert Labs BUTALBITAL, ACETAMINOPHEN AND CAFFEINE acetaminophen; butalbital; caffeine CAPSULE;ORAL 088825-001 Dec 5, 1984 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Hikma Pharms BUTALBITAL, ACETAMINOPHEN AND CAFFEINE acetaminophen; butalbital; caffeine TABLET;ORAL 040336-001 Aug 18, 1999 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Specgx Llc BUTALBITAL, ACETAMINOPHEN AND CAFFEINE acetaminophen; butalbital; caffeine TABLET;ORAL 087804-001 Jan 24, 1985 AA RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
US Army
Accenture
Covington
Fish and Richardson
Colorcon
Merck
UBS
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.